A7HBF2 AF NFT

Glutamyl-tRNA reductase 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiasibybcejib5l46u6zojzyfyghzgeg7g3eew7a5wqriswfpwh4ja/metadata.json
IPFS of structure file: 
bafybeiacxrfgyyur2czxdk3u3vbwg5jo3zpty4773cf6st3vjv4ihckujm/AF-A7HBF2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xa035E6D3B1efC66Af27788374F32B4851461992f
First NFT owner address (bech32): 
genesis15q67d5a3alrx4unh3qm57v45s52xrxf0k4ph5u
Current NFT ID #166407 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
166407
Accession (UniProt):
A7HBF2
Name::
Glutamyl-tRNA reductase 2
Experimental Method:
Predicted structure
Sequence source:
ANAEROMYXOBACTER SP. (STRAIN FW109-5)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A7HBF2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A7HBF2|HEM12_ANADF Glutamyl-tRNA reductase 2 OS=Anaeromyxobacter sp. (strain Fw109-5) OX=404589 GN=hemA2 PE=3 SV=2 MLVAVGLNQKGATVADREVLALPAEGFQSTLAEYAALDAVDEIAVMSTCYRVEIYAATRCPAAATLSLRQALNARAGRELPLFELHGEEAYRHLVRVASSLESAILGEPQILGQVKEAFQRSIDQGVAAKELTSVLNRALSAAKRVRTDTAIGRAGISWGHAAATLAEKVLGKMQGRRVVVVGAGEMARLSAQHLRDQGARIVVLNRTLVNGEALAREVGGVARPLEALGEELAQADVVVSAAPVAPDAFQPEAMAELSRSRKRPIVLVDLAVPRAIPAATGAIRDVYLCDVDDLDRVMKAAMSERAAAVADADRIIAEEVGKFVRAEAERRAAPLIQEMRTRASAIAREEVERTLRRLGEDPEVERRLEAMAGSIVSKILHAPSARLRQAVCDGCSGEALVSAAVEIFELSADIRVHRGNAA